All diagnostic codes
F11Substance Use Disorders

Mental and Behavioural Disorders Due to Opioid Use (F11)

DSM-5-TR: Opioid Use Disorder

ICD-10-AM and DSM-5-TR may classify conditions differently. Refer to APA and WHO for complete diagnostic criteria.

Key Facts

ICD-10 Range

F10-F19

Subcodes

5 subcodes

Australian Prevalence

Approximately 0.4% of Australians have an opioid use disorder. Opioid-related deaths are a significant public health concern, with prescription opioids accounting for the majority of opioid-related fatalities.

Global Prevalence

WHO estimates approximately 16 million people worldwide have an opioid use disorder. Opioid-related harm accounts for approximately two-thirds of the 500,000 deaths attributable to drug use globally.

Duration Requirement

Dependence syndrome (F11.2): three or more features present simultaneously for at least one month, or repeatedly within a 12-month period

Overview

Covers disorders arising from the use of opioids including heroin, morphine, codeine, and prescription opioids such as oxycodone and fentanyl. Presentations range from acute intoxication to dependence and withdrawal syndromes.

Diagnostic Criteria (ICD-10)

Core Features

  • Strong desire or compulsion to use opioids
  • Difficulty controlling opioid use in terms of onset, termination, or amount
  • Physiological withdrawal state when opioid use is reduced or stopped
  • Evidence of tolerance — increased doses required for the same effect
  • Progressive neglect of alternative pleasures or interests
  • Persistent use despite clear evidence of harmful consequences

Duration

Dependence syndrome (F11.2): three or more features present simultaneously for at least one month, or repeatedly within a 12-month period

Exclusion Criteria

  • Opioid use for pain management under medical supervision without features of dependence

ICD-10-AM Subcodes

CodeName
F11.0Acute intoxication
F11.1Harmful use
F11.2Dependence syndrome
F11.3Withdrawal state
F11.5Psychotic disorder
F11.0Transient condition following opioid ingestion, characterised by miosis, reduced consciousness, respiratory depression, and analgesia.
F11.1Pattern of opioid use causing damage to physical or mental health.
F11.2A cluster of physiological, behavioural, and cognitive phenomena with strong desire to use opioids, difficulty controlling use, and physiological withdrawal on cessation.
F11.3Symptoms occurring on absolute or relative withdrawal of opioids after repeated or prolonged use, including anxiety, sweating, nausea, vomiting, muscle aches, and lacrimation.
F11.5Psychotic phenomena occurring during or after opioid use, less common than with stimulants.

Classification Boundaries

Includes

  • Opioid dependence
  • Heroin dependence
  • Morphine dependence

Australian Clinical Context

Opioid-related deaths are a significant public health concern in Australia. PBS-subsidised opioid substitution therapy (OST) includes methadone and buprenorphine/naloxone (Suboxone). The National Opioid Pharmacotherapy Program oversees OST access. Take-home naloxone programs are available in all states and territories.

Medicare (MBS) Pathways

Better Access to Mental Health Care

The primary Medicare pathway for mental health treatment in Australia. Requires a GP Mental Health Treatment Plan (MHTP) referral. Available for any clinically diagnosed mental disorder.

10 individual + 10 group sessions per calendar year

Clinical Psychologist

80000–80025Psychological therapy (higher rebate)

Registered Psychologist

80100–80123Focused psychological strategies

Occupational Therapist

80125–80145Focused psychological strategies

Social Worker

80150–80175Focused psychological strategies

Psychiatrist

291, 296–299, 300–308Psychiatric consultation

GP referral items: 2700, 2701, 2715, 2717

Eligibility: Any clinically diagnosed mental disorder as defined by WHO ICD-10 Chapter V. Requires a GP or psychiatrist referral.

Exclusions:

  • Intellectual disability (use Complex Neurodevelopmental Disorder pathway or specialist referral)
  • Dementia and organic mental disorders (use specialist referral pathway)
  • Tobacco use disorder

Opioid substitution therapy (OST) is funded through PBS, not MBS Better Access. Psychological treatment for comorbid conditions is covered under Better Access.

Automate MBS item capture from your sessions

Grounded Scribe suggests the right MBS item codes from your recording so you can claim accurately without re-keying.

Reference information sourced from MBS Online (mbsonline.gov.au). Item availability, rebates, and eligibility criteria may change. This is not billing advice — always verify current items before claiming. Last verified: April 2026.

Clinical Documentation Notes

The COWS (Clinical Opiate Withdrawal Scale) monitors opioid withdrawal severity. Document substance type (heroin vs prescription opioids), route of administration, dose, frequency, and withdrawal history. RANZCP and RACP guidelines support opioid substitution therapy as first-line treatment for dependence.

Related Diagnostic Codes

ICD-10-AM diagnostic codes commonly associated with the Mental and Behavioural Disorders Due to Opioid Use (F11).

Frequently Asked Questions

References

  1. World Health Organization. ICD-10-AM.
  2. American Psychiatric Association. DSM-5-TR. 2022.
  3. AIHW. National Drug Strategy Household Survey.

Clinical Scoring Calculator — Not a Diagnostic Tool

This tool calculates scores based on published guidelines for professional reference. It does not provide clinical diagnoses. Scores are provided as reference information only and should be interpreted by a qualified practitioner in the context of a comprehensive assessment.

Document sessions for patients with opioid use disorder

Grounded Scribe automatically generates clinical notes from your sessions, saving hours of documentation time.

Start free trial
No credit card required

Start Documenting in Minutes.Not Hours.

Free plan. No credit card. Cancel anytime.

F11 Opioid Use Disorder — ICD-10-AM & DSM-5-TR Reference | Grounded Scribe | Grounded Scribe